Cargando…
Prostaglandin Reductase 1 as a Potential Therapeutic Target for Cancer Therapy
Altered tumor metabolism is a hallmark of cancer and targeting tumor metabolism has been considered as an attractive strategy for cancer therapy. Prostaglandin Reductase 1 (PTGR1) is a rate-limiting enzyme involved in the arachidonic acid metabolism pathway and mainly responsible for the deactivatio...
Autores principales: | Wang, Xing, Yin, Guobing, Zhang, Wei, Song, Kunling, Zhang, Longbin, Guo, Zufeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377670/ https://www.ncbi.nlm.nih.gov/pubmed/34421612 http://dx.doi.org/10.3389/fphar.2021.717730 |
Ejemplares similares
-
Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy
por: Wang, Xing, et al.
Publicado: (2023) -
Biliverdin reductase: a target for cancer therapy?
por: Gibbs, Peter E. M., et al.
Publicado: (2015) -
Eicosanoids in Cancer: Prostaglandin E(2) Receptor 4 in Cancer Therapeutics and Immunotherapy
por: Ching, Mc Millan, et al.
Publicado: (2020) -
The Prostaglandin F Synthase Activity of the Human Aldose Reductase AKR1B1 Brings New Lenses to Look at Pathologic Conditions
por: Bresson, Eva, et al.
Publicado: (2012) -
Compounds targeting ferroptosis in breast cancer: progress and their therapeutic potential
por: Xu, Chuchu, et al.
Publicado: (2023)